The GSK oncology products it has sold on to Novartis were ... particularly if GSK is not looking to reinvest in oncology. However a major outlay looks unlikely, at least in connection to the ...
GlaxoSmithKline’s new CEO Emma Walmsley is set to outline her vision for the company alongside half-year results next month – but reports suggest that she may shake up the consumer products ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback